Growth inhibition of human pancreatic cancer cell lines by anti-sense oligonucleotides specific to mutated K-ras genes

International Journal of Cancer

Volumn 80, Issue 4, 1999, Pages 553-558

  Kita, Kei Ichiro ^a   Saito, Seiji ^a   Morioka, Cintia Y ^a   Watanabe, Akiharu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; LIPOSOME; MESSENGER RNA; PROTEIN P21;

ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DNA TRANSFECTION; GENE THERAPY; HUMAN; HUMAN CELL; ONCOGENE K RAS; PANCREAS CANCER; POINT MUTATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG SCREENING ASSAYS, ANTITUMOR; GENES, RAS; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PANCREATIC NEOPLASMS; POINT MUTATION; RAS PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033521860     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990209)80:4<553::AID-IJC12>3.0.CO;2-6     Document Type: Article

References (26)

1. ALBERTS, B., BRAY, D., LEWIS, J., RAFF, M., ROBERTS, K. and WATSON, J.D., The molecular genetics of cancer. In: B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts and J.D. Watson (eds.), Molecular biology of the cell, pp. 1273-1290, Garland, New York (1994).
2. AOKI, K., YOSHIDA, T., SUGIMURA, T. and TERADA, M., Liposome-mediated in vivo gene transfer of anti-sense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. Cancer Res., 55, 3810-3816 (1995).
3. BERROZPE, G., SCHAEFFER, J., PEINADO, M.A., REAL, F.X. and PERUCHO, M., Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int. J.Cancer. 58, 185-191 (1994).
4. BOS, J.L., ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689 (1989).
5. CALDAS, C. and KERN, S.E., K-ras mutation and pancreatic adenocarcinoma. Int. J. Pancreatol., 18, 1-6 (1995).
6. CARTER, G., GILBERT, C. and LEMOINE, N.R., Effects of anti-sense oligonucleotides targeting K-ras expression in pancreatic cancer cell lines. Int. J. Oncol., 6, 1105-1112 (1995).
7. CARTER, G. and LEMOINE, N.R., Anti-sense technology for cancer therapy: does it make sense?. Brit. J. Cancer. 67, 869-876 (1993).
8. CHANG, E.H., MILLER, P.S., CUSHMAN, C., DEVADAS, K., PIROLLO, K.F., TS'O, P.O. and YU, Z.P., Anti-sense inhibition of ras p21 expression that is sensitive to a point mutation. Biochemistry, 30, 8283-8286 (1991).
9. DAAKA, Y. and WICKSTRÖM, E., Target dependence of anti-sense oligodeoxynucleotide inhibition of c-Ha-rasp21 expression and focus formation in T24-transformed NIH3T3 cells. Oncogene Res., 5, 267-275 (1990).
10. DUROUX, I., GODARD, G., BOIDOT-FORGET, M., SCHWAB, G., HELENE, C. and SAISON-BEHMOARAS, T., Rational design of point mutation-selective anti-sense DNA targeted to codon 12 of Ha-rasmRNA in human cells. Nucleic Acids Res., 23, 3411-3418 (1995).
11. HIGGINS, K.A., PEREZ, J.R., COLEMAN, T.A., DORSHKIND, K., MCCOMAS, W.A., SARMIENTO, U.M., ROSEN, C.A. and NARAYANAN, R., Anti-sense inhibition of the p65 subunit of NF-k B blocks tumorigenicity and causes tumor regression. Proc. nat. Acad. Sci. (Wash.), 90, 9901-9905 (1993).
12. KAWADA, M., FUKAZAWA, H., MIZUNO, S. and UEHARA, Y., Inhibition of anchorage-independent growth of ras-transformed cells on polyHEMA surface by anti-sense oligodeoxynucleotides directed against K-ras. Biochem. biophys. Res. Comm., 231, 735-737 (1997).
13. KOBAYASHI, I., Growth inhibition of gastrointestinal cancer by anti-sense oligonucleotides (in Japanese). Osaka Daigaku Igaku Zasshi, 47, 407-415 (1995).
14. LEVI, S., URBANO-ISPIZUA, A., GILL, R., THOMAS, D.M., GILBERTSON, J., FOSTER, C. and MARSHALL, C.J., Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res., 51, 3497-3502 (1991).
15. LIU, T.H., LI, D.C. and WANG, Z.Y., The inhibitory effect of anti-sense oligodeoxynucleotides on the growth of human pancreatic adenocarcinoma cell lines (in Chinese). Chin. J. Pathol., 22, 25-29 (1993).
16. MARIYAMA, M., KISHI, K., NAKAMURA, K., OBATA, H. and NISHIMURA, S., Frequency and types of point mutation at the 12th codon of the C-Ki-rasgene found in pancreatic cancers from Japanese patients. Jpn. J. Cancer Res., 80, 622-626 (1989).
17. MONIA, B.P., JOHNSTON, J.F., ECKER, D.J., ZOUNES, M.A., LIMA, W.F. and FREIER, S.M., Selective inhibition of mutant Ha-ras mRNA expression by anti-sense oligonucleotides. J. biol. Chem., 267, 19954-19962 (1992).
18. MOSMANN, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. immunol. Methods, 65, 55-63 (1983).
19. NECKERS, L., WHITESELL, L., ROSOLEN, A. and GESELOWITZ, D.A., Anti-sense inhibition of oncogene expression. Crit. Rev. Oncogenes, 3, 175-231 (1992).
20. NISHIMURA, N., SAITO, S., KUBOTA, Y., MOTO-O, N., TAGUCHI, K., YAMAZAKI, K., WATANABE, A. and SASAKI, H., Newly established human pancreatic carcinoma cell lines and their lectin binding properties. Int. J. Pancreatol., 13, 31-41 (1993).
21. SAISON-BEHMOARAS, T., TOCQUE, B., REY, I., CHASSIGNOL, M., THUONG, N.T. and HÉLÈNE, C., Short modified anti-sense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cell proliferation. EMBO J., 10, 1111-1118 (1991).
22. SAITO, S. and SASAKI, H., Introduction of the cultured cell lines, liver, biliary tract, pancreas [in Japanese]. Hum. Cell, 1, 124-125 (1988).
23. SAKAKURA, C., HAGIWARA, A., TSUJIMOTO, H., OZAKI, K., SAKAKIBARA, T., OYAMA, T., OGAKI, M., IMANISHI, T. YAMAZAKI, J. and TAKAHASHI, T., Inhibition of colon cancer cell proliferation by anti-sense oligonucleotides targeting the messenger RNA of the Ki-ras gene. Anticancer Drugs, 6, 553-561 (1995).
24. STEIN, C.A. and CHENG, Y.C., Anti-sense oligonucleotides as therapeutic agents - is the bullet really magical? Science, 261, 1004-1012 (1993).
25. TADA, M., OMATA, M. and OHTO, M., Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology, 100, 233-238 (1991).
26. H p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs. Mol. cell. Biol., 4, 1647-1652 (1984).